Correlation Between JPMorgan Chase and Helix BioPharma

Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Helix BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Helix BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between JPMorgan Chase Co and Helix BioPharma Corp, you can compare the effects of market volatilities on JPMorgan Chase and Helix BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Helix BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Helix BioPharma.

Diversification Opportunities for JPMorgan Chase and Helix BioPharma

-0.09

Correlation Coefficient

JPMorgan Chase  Helix BioPharma

Good diversification

The 3 months correlation between JPMorgan and Helix is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Helix BioPharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Helix BioPharma Corp and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Helix BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Helix BioPharma Corp has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Helix BioPharma go up and down completely randomly.

Pair Corralation between JPMorgan Chase and Helix BioPharma

Assuming the 90 days trading horizon JPMorgan Chase is expected to generate 1.48 times less return on investment than Helix BioPharma. But when comparing it to its historical volatility, JPMorgan Chase Co is 3.93 times less risky than Helix BioPharma. It trades about 0.18 of its potential returns per unit of risk. Helix BioPharma Corp is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  89.00  in Helix BioPharma Corp on December 2, 2024 and sell it today you would earn a total of  9.00  from holding Helix BioPharma Corp or generate 10.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

JPMorgan Chase Co  vs.  Helix BioPharma Corp

JPMorgan Chase

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very abnormal basic indicators, JPMorgan Chase may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Helix BioPharma Corp

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Helix BioPharma Corp are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Helix BioPharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with JPMorgan Chase and Helix BioPharma

The main advantage of trading using opposite JPMorgan Chase and Helix BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Helix BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Helix BioPharma will offset losses from the drop in Helix BioPharma's long position.

The idea behind JPMorgan Chase Co and Helix BioPharma Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.